Catalyst Pharmaceuticals, Inc.

• locale

  United States

• market

  STOCKS

• industry

  Biotechnology

• website

  catalystpharma.com

• ipo date

  Nov 08, 2006

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.